OCT defines the macular edema and tracks response
UKE lists OCT, retinal examination and fluorescein angiography among the diagnostic tools for diabetic retinal disease. OCT shows retinal thickening and fluid in the macula and is useful for comparing anatomy over time. Fluorescein or OCT angiography may be added when vascular leakage, ischemia or another retinal question needs clarification.
Intravitreal treatment is usually a repeated pathway
UKE states that diabetic macular edema is now generally treated primarily with injections into the eye, while University Hospital Cologne documents intravitreal VEGF inhibitors and corticosteroids for DME. The exact medicine and interval are individualized according to anatomy, visual function, previous response, lens status and ocular risks. International patients should therefore plan for serial OCT and repeated treatment rather than assume one injection completes care.
Steroids and laser are selected options, not automatic substitutes
Corticosteroid intravitreal treatment may be considered in selected eyes, but lens status, intraocular pressure and glaucoma risk are relevant to the decision. UKE also notes that central retinal laser is occasionally added, while Cologne documents laser treatment within diabetic retinal care. The retina specialist should explain why an adjunct is being chosen for that specific eye.
Systemic diabetes control remains part of retinal care
UKE emphasizes consistent blood-glucose management alongside ocular treatment. For a second opinion, the retina team should know the broader diabetes context, including recent HbA1c trend, blood-pressure control, kidney disease and relevant cardiovascular history. Improving systemic risk factors does not replace treatment of sight-threatening retinal disease, but the two parts of care should not be separated.
Vitrectomy is for selected complications, not routine DME
More advanced diabetic retinal disease can cause vitreous hemorrhage, tractional membranes or other complications that may require vitrectomy. UKE describes vitreous removal, membrane work and additional retinal treatment in severe disease. A patient with uncomplicated DME should not be routed to surgery merely because the word 'edema' appears on an OCT report.
Prepare a longitudinal diabetes-and-retina record
Serial data are especially useful because DME management depends on both anatomy and response over time.
- Recent macular OCT images and reports from both eyes
- Earlier OCT scans for comparison
- Current and previous visual acuity
- Fundus photographs if available
- Fluorescein or OCT angiography if previously performed
- Exact injection history: medicine, dates and response
- Previous retinal laser or steroid treatment
- Lens status and cataract history
- Eye-pressure or glaucoma history
- Recent HbA1c values and diabetes medication
- Blood-pressure and kidney-disease history when relevant
Sudden major visual loss needs prompt local assessment
A sudden marked decrease in vision can reflect hemorrhage, retinal detachment or another complication rather than stable macular edema. Urgent new symptoms should be assessed locally without delaying care for international travel planning.
Official sources
Sources last checked 2026-09-13. Ophthalmic treatment can be time-sensitive, so confirm current recommendations directly with the treating eye team.
- Diabetic retinal disease – diagnosis and treatment — University Medical Center Hamburg-Eppendorf (UKE) ↗
- Retinal diseases – diabetic retinopathy, DME, OCT and intravitreal therapy — University Medical Center Hamburg-Eppendorf (UKE) ↗
- Ophthalmology MVZ – IVOM, diabetic macular edema and retinal diagnostics — University Hospital Cologne ↗
- Retinal surgery, laser treatment and intravitreal injections — University Hospital Cologne ↗
- Retinology – OCT, angiography and diabetic retinopathy research — University Medical Center Freiburg ↗